Cambinol
An inhibitor of NAD-dependent deacetylase activity of human SIRT1 (IC₅₀ = 56 µM) and SIRT2(IC₅₀ = 59 µM). Acts as an antitumor agent. Treatment of BCL6-expressing Burkitt lymphoma cells with Cambinol induces apoptosis accompanied by hyperacetylation of BCL6 and p53.
Product Specifications
Shipping Conditions
RT
Storage Conditions
+4°C
Shelf Life
24 months
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog